comparemela.com
Home
Live Updates
Aramis Study - Breaking News
Pages:
Latest Breaking News On - Aramis study - Page 1 : comparemela.com
Importance of Quality of Life When Choosing Therapy for nmCRPC
A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.
Key updates
Metastatic prostate cancer treatment
Life when choosing therapy
Prostate cancer
Nonmetastatic castration resistant prostate cancer
Ar inhibitors
Androgen receptor inhibitors
Quality of life
Qol data
Spartan trial
Spartan study
Prosper trial
Prosper study
Aramis trial
Aramis study
AR Inhibitors in nmCRPC: Real-World Data
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
Key updates
Metastatic prostate cancer treatment
Real world data
Prostate cancer
Nonmetastatic castration resistant prostate cancer
Ar inhibitors
Androgen receptor inhibitors
Dear study
Dear trial
Spartan trial
Spartan study
Prosper trial
Prosper study
Aramis trial
Aramis study
nmCRPC: Clinical Trial Data on AR Inhibitors
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.
Key updates
Metastatic prostate cancer treatment
Clinical trial data
Prostate cancer
Nonmetastatic castration resistant prostate cancer
Spartan trial
Spartan study
Prosper trial
Prosper study
Aramis trial
Aramis study
Metastasis free survival
Mfs survival
Overall survival
Survival data
Ar inhibitors
vimarsana © 2020. All Rights Reserved.